A synthetic opioid so powerful it makes fentanyl appear mild by comparison is quietly carving a path of death through American communities, and health officials across the country are racing to catch up.
Cychlorphine, also known by its scientific name N-Propionitrile Chlorphine, is a chemically manufactured opioid that global health authorities first began tracking in mid-2024.
Forensic investigators in Tennessee have now tied the drug to at least 41 deaths across 11 counties, all occurring between July 2025 and February 2026, according to a notice released Monday, April 6, by the Knox County Regional Forensic Center.
The affected Tennessee counties span a wide geographic footprint: Anderson, Blount, Campbell, Claiborne, Grainger, Jefferson, Knox, McMinn, Roane, Sevier and Union, with five more deaths flagged for early-stage review.
Early laboratory analysis places cychlorphine’s potency at roughly ten times that of fentanyl, a synthetic opioid already responsible for a staggering share of American overdose fatalities.
Synthetic opioids collectively account for the leading share of overdose deaths in the United States, making the emergence of an even more potent compound a serious escalation of an already severe public health crisis.
Chris Thomas, chief administrative officer and director of the Knox County Regional Forensic Center, did not mince words when describing the situation his office is confronting.
“What’s especially troubling is that cychlorphine may have been circulating far longer than we know,” Thomas said in a public statement. “And I’ve said this before – we don’t know if it’s contained to a limited supply or one bad batch, or if it’s representative of a longer-term shift in the drug supply. That’s what is really concerning.”
Thomas added a blunt warning directed at anyone who uses street drugs.
“It has never been more dangerous to take street-level drugs than right now,” he said.
Early reports from forensic investigators point to China as the likely point of origin for cychlorphine, from which the drug is believed to have traveled through European markets before establishing a foothold in the United States.
The substance falls within a growing subclass of synthetic compounds called “orphines” or “orphine analogues,” chemically engineered to replicate the effects of established opioids like morphine while slipping past existing drug laws and conventional testing panels.
It circulates on the street in powder and tablet form, and is frequently mixed with other illicit substances including heroin, compounding the danger for users who may have no idea what they are actually consuming.
The Center for Forensic Science Research and Education, or CFSRE, sounded a national alarm in January, describing an alarming surge in cychlorphine-linked deaths across the United States and in countries spanning Canada, Europe and Oceania.
As of that January alert, the CFSRE had confirmed the drug’s presence in seven states: New York, California, Illinois, Nevada, Pennsylvania, Tennessee and Texas.
Since then, Florida, Kentucky, Oklahoma and South Carolina have each issued separate public warnings after confirming cychlorphine activity within their borders.
Aegis Labs toxicology data has further detected the substance in Arkansas, Indiana, Maine, Maryland, Massachusetts, Missouri, New Hampshire, Ohio and West Virginia, bringing the total number of states with confirmed presence to approximately two dozen.
The drug presents a compounding detection problem for first responders and medical examiners alike.
Standard toxicology screening panels used in hospitals and by law enforcement are not built to identify cychlorphine, according to the Addiction Center, meaning deaths caused by the substance can go uncategorized or be attributed to other causes entirely.
Even when a cychlorphine overdose is identified, treatment is complicated. Naloxone, the opioid reversal drug marketed as Narcan, may not work as effectively against the compound’s potency and could require multiple doses to produce results.
Like other opioids in its class, cychlorphine acts by overwhelming the body’s respiratory system in very small quantities, leaving victims unconscious or unable to breathe with frightening speed.
Thomas noted the possibility that the drug’s timeline in American communities stretches back further than current data reflects, given how long it may have gone undetected in jurisdictions without specialized testing capabilities.
